Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02844439
Title Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kadmon Corporation, LLC
Indications

glioblastoma

Therapies

Tesevatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.